Lates News

C4 Therapeutics (C4.US): The Q3 financial report for 2025 achieved revenue of $11.23 million, compared to $15.36 million in the previous period and expected revenue of $6.368 million. Earnings per share were -$0.44, compared to -$0.35 in the previous period and expected earnings of -$0.42.